国际麻醉学与复苏杂志   2018, Issue (1): 0-0
    
过氧化物酶增殖物激活受体α/过氧化物酶增殖物激活受体γ和痛觉过敏关系的研究进展
张佐霞, 刘玥, 马正良1()
1.南京大学医学院附属鼓楼医院
Research advances on the relationship between peroxisome proliferator-activated receptor α/ peroxisome proliferator-activated receptor γ and hyperalgesia
 全文:
摘要:

背景 过氧化物酶增殖物激活受体(peroxisome proliferator-activated receptors, PPARs)属于配体依赖性激活的核受体转录因子超家族,它包括3种亚型,即PPARα、PPARβ/δ和PPARγ,主要参与体内细胞增殖与分化、物质能量代谢以及炎症反应。近年研究发现:特异性激活PPARα/PPARγ后,可以有效预防痛觉过敏的发生发展。 目的 探讨PPARα/PPARγ在痛觉过敏发生发展中的作用。 内容 对PPARα/PPARγ与痛觉过敏的关系进行综述。 趋向 为痛觉过敏的防治提供新思路、新办法。

关键词: 过氧化物酶增殖物激活受体; 痛觉过敏
Abstract:

Background Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors belong to a nuclear hormone receptor superfamily, containing three family members: PPARα, PPARβ/δ and PPARγ. PPARs play a critical physiological role in cell proliferation and differentiation, substance metabolism, energy homeostasis and inflammatory response. Recently, PPARα/PPARγ agonists were reported preventing the occurrence and development of hyperalgesia. Objective To investigate the role of PPARα/PPARγ in the occurrence and development of hyperalgesia. Content Reviewing the relationship between PPARα/PPARγ and hyperalgesia. Trend To provide new methods for prevention and treatment of hyperalgesia.

Key words: Peroxisome proliferator-activated receptors; Hyperalgesia